Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy

doi:10.1016/0167-8140(90)90163-Q

Radiotherapy and Oncology

Volume 19, Issue 1, September 1990, Pages 29-41

https://doi.org/10.1016/0167-8140(90)90163-Q Get rights and content

Abstract

The identification of factors associated with breast recurrence following conservative surgery (CS) and radiation therapy (RT) is of potential use in refining patient selection criteria and treatment technique. In an attempt to define such factors we examined the relationship between various clinical, pathologic and treatment characteristics and the likelihood of breast recurrence in 783 patients with clinical stage I or II breast cancer treated between July 1968 and December 1982. Treatment consisted of complete gross excision of the primary tumor and RT to a total dose of at least 60 Gy to the primary site. During this period, pre-treatment mammograms and detailed histologic assessment of the margins of resection were not routinely performed. Median follow-up for surviving patients was 80 months. Thirteen patients (1.6%) were lost to follow-up. Ninety-one patients (12%) have developed a breast recurrence, corresponding to 5- and 10-year actuarial rates of 10 and 18%, respectively. The major feature associated with breast recurrence was the presence of an “extensive intraductal component” (EIC +). An EIC + tumor was seen in 28% of evaluable cases with infiltrating ductal carcinoma and accounted for 60% of breast recurrences. Forty-three of 166 patients (26%) with EIC + tumors developed a breast recurrence compared with 29 of 418 patients (7%) without an EIC (EIC −) (p = 0.0001). The 5-year actuarial rates of breast relapse were 24 and 6%, respectively (p = 0.0001). Very young age (defined as 34 years of age or younger) was also a significant factor associated with the risk of breast recurrence. Very young patients comprised 8% of the patient population and accounted for 16% of breast recurrences. Fifteen of 61 very young patients (25%) developed a breast recurrence compared with 76 of 722 older patients (11%) (p = 0.001). The corresponding 5-year actuarial rates of breast recurrence were 21 and 9% (p = 0.005). None of the other clinical or pathological factors examined by univariate analysis were significantly correlated with recurrence in the breast. A multivariate model of site of first failure (polychotomous logistic regression) also showed that EIC + tumors and very young age were the main factors associated with a high relative risk of breast recurrence. We conclude that EIC + tumors and very young age are associated with a high risk of breast recurrence for patients treated with limited excision prior to RT.

References (28)

H. Bartelink et al.
The impact of tumor size and histology on local control after breast-conserving therapy
Radiother. Oncol.
(1988)
R. Calle et al.
Local control and survival of breast cancer treated by limited surgery followed by irradiation
Int. J. Radiat. Oncol. Biol. Phys.
(1986)
D.H. Clarke et al.
Analysis of local-regional relapse in patients with early breast cancers treated by excision and radiotherapy. Experience of the Institut Gustave-Roussy
Int. J. Radiat. Oncol. Biol. Phys.
(1985)
G. Delouche et al.
Conservation treatment of early breast cancer: long term results and complications
Int. J. Radiat. Oncol. Biol. Phys.
(1987)
J.R. Harris et al.
Primary radiation therapy for early breast cancer: the experience at the Joint Center for Radiation Therapy
Int. J. Radiat. Oncol. Biol. Phys.
(1981)
J.M. Kurtz et al.
Mammary recurrences in women younger than forty
Int. J. Radiat. Oncol. Biol. Phys.
(1988)
M.P. Nobler et al.
Prognostic factors in patients undergoing curative irradiation for breast cancer
Int. J. Radiat. Oncol. Biol. Phys.
(1985)
A. Recht et al.
Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma
Int. J. Radiat. Oncol. Biol. Phys.
(1989)
A. Recht et al.
Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage
Int. J. Radiat. Oncol. Biol. Phys.
(1985)
M.A. Rose et al.
Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure
Int. J. Radiat. Oncol. Biol. Phys.
(1989)

L.J. Solin et al.

Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer

Int. J. Radiat. Oncol. Biol. Phys.

(1987)

G.K. Svensson et al.

A modified three-field technique for breast treatment

Int. J. Radiat. Oncol. Biol. Phys.

(1980)

E. Van Limbergen et al.

Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control

Radiother. Oncol.

(1987)

J.R. Vilcoq et al.

The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer

Int. J. Radiat. Oncol. Biol. Phys.

(1981)

Cited by (221)

Special issue. De-escalation of loco-regional treatment in breast cancer: Time to find the balance? Partial breast irradiation
2023, Breast
Breast cancer is the most common cancer in women worldwide. Over the past few decades, remarkable progress has been made in understanding the biology and pathology of breast cancer. A personalized conservative approach has been currently adopted addressing the patient's individual risk of relapse. After postoperative whole breast irradiation for early-stage breast cancer, a rate of recurrences outside the initial tumour bed lower than 4% was observed. Thus, the highest benefits of breast irradiation seem to result from the dose delivered to the tissue neighbouring the tumour bed. Nonetheless, reducing treatment morbidity while maintaining radiation therapy's ability to decrease local recurrences is an important challenge in treating patients with radiation therapy. In this regard, strategies such as partial-breast irradiation have been developed to reduce toxicity without compromising oncologic outcomes. According to the national and international published guidelines, clinical oncologists can refer to specific dose/fractionation schedules and eligible criteria. However, there are still some areas of open questions. Breast cancer represents a multidisciplinary paradigm; it should be considered a heterogeneous disease where a “one-treatment-fits-all” approach cannot be considered an appropriate option. This is a wide overview on the main partial breast irradiation advantages, risks, timings, techniques, and available recommendations. We aim to provide practical findings to support clinical decision-making, exploring future perspectives, towards a balance for optimisation of breast cancer.
Extensive Intraductal Component in Breast Cancer: What Role in Disease-Free Survival?
2023, Journal of Surgical Research
Extensive intraductal component (EIC) associated to early breast cancer could increase the risk locoregional recurrence, but its impact on distant metastases is still unclear. The aim of the present study was to assess the role of EIC on 5-year survival outcomes in patients affected by early breast cancer treated with breast-conserving surgery.
A total of 414 consecutive patients with a minimum follow-up of 60 mo were collected from January 2007 to December 2015. Disease-free survival (DFS), distant metastasis-free survival (DMFS), and locoregional recurrence-free survival at 5 y were assessed considering the presence or absence of EIC and other clinical and pathological features.
Absence of EIC was independently associated with worse 5-year DFS (hazard ratio [HR] 1.68, P = 0.008) and 5-year DMFS (HR 1.93, P = 0.007), whereas 5-year locoregional recurrence-free survival was not affected (HR 1.50, P = 0.16). Five-year DFS was increased by EIC in T1 patients (P = 0.03) but not in T2 stage. Moreover, EIC was associated to better DFS in G2 (P = 0.03) and G3 patients (P = 0.01) but not in G1 cases.
Our results suggest that EIC is independently correlated with increased 5-year DFS and in particular with 5-year DMFS.
The Accuracy of Mammography, Ultrasound, and Magnetic Resonance Imaging For the Measurement of Invasive Breast Cancer With Extensive Intraductal Components
2023, Clinical Breast Cancer
The precise preoperative evaluation of radiologic tumor size with extensive intraductal component (EIC) is important. This study compared the accuracy of mammography, ultrasound (US), and magnetic resonance imaging (MRI) to measure invasive breast cancer with EIC.
Between 2007 and 2012, we collected data from 6816 patients who underwent surgery for invasive breast cancer at our institution. We reviewed the postoperative surgical reports of the tumors, in which the invasive tumor size and EIC were measured separately. Finally, we included 370 women who underwent preoperative mammography, US, and MRI. Each modality was retrospectively reviewed to measure the size of invasive breast cancer with EIC. The reference standard was surgical pathologic size and the accuracies of the image were evaluated.
Spearman's correlation coefficient for the size of invasive cancer with EIC was good between MRI (r = 0.741) and pathology, and moderate between mammography (r = 0.661) or US (r = 0.514) and pathology. Both mass and nonmass lesions showed good correlations (intraclass correlation coefficient [ICC] = 0.672 and 0.612, respectively) in MRI. Furthermore, the subgroup of tumors without microcalcifications showed a higher correlation with MRI (ICC = 0.796) than with mammography (ICC = 0.620). However, the subgroup with microcalcifications showed a good correlation with mammography (ICC = 0.702) compared to MRI (ICC = 0.680) and US (ICC = 0.532).
The lesion on mammography, US, and MRI reflected preoperative size of invasive cancer with EIC. MRI shows a higher correlation than mammography and US. However, cancer with calcifications of mammography shows a more accurate size than MRI or US.
Breast imaging screening and diagnosis
2018, The Breast: Comprehensive Management of Benign and Malignant Diseases
A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
2017, American Journal of Surgery
Citation Excerpt :
In a study by Ballard-Barbash et al., patients aged 65 to 69 received recommended radiation 76% of the time while patients aged 70 to 74 only 68% of the time and patients 75–79 years old only 56% of the time.9 Data indicates that when an ipsilateral breast cancer recurrence occurs, 90% of the time it recurs in the index quadrant, near the site of the original tumor.10–14 Based upon this information, accelerated partial breast irradiation (APBI) was a method of radiation developed to target radiation into the tumor bed while sparing the rest of the normal breast parenchyma.
Single-session intraoperative radiation therapy (IORT) minimizes treatment demands associated with traditional whole breast radiation therapy (WBRT) but outcomes on local disease control and morbidity among the elderly is limited.
A multi-institutional retrospective registry was established from 19 centers utilizing IORT from 2007 to 2013. Patient, tumor, and treatment variables were analyzed for ages <70 and ≥70.
We evaluated 686 patients (<70 = 424; ≥70 = 262) who were margin and lymph node negative. Patients <70 were more likely to have longer operative time, oncoplastic closure, higher rates of IORT used as planned boost, and receive chemotherapy and post-operative WBRT. Wound complication rates were low and not significantly different between age groups. Median follow-up was 1.06 (range 0.51–1.9) years for < 70 and 1.01 (range 0.5–1.68) years for ≥ 70. There were 5 (0.73%) breast recurrences (4 in <70 and 1 ≥ 70, p = 0.65) and no axillary recurrences during follow-up.
IORT was associated with a low rate of wound complication and local recurrence on short-term follow-up in this cohort.
Rough set based rule induction in decision making using credible classification and preference from medical application perspective
2016, Computer Methods and Programs in Biomedicine
This paper presents a new heuristic algorithm for reduct selection based on credible index in the rough set theory (RST) applications. This algorithm is efficient and effective in selecting the decision rules particularly the problem to be solved in a large scale. This algorithm is capable to derive the rules with multi-outcomes and identify the most significant features simultaneously, which is unique and useful in solving predictive medical problems. The end results of the proposed approach are a set of decision rules that illustrates the causes for solitary pulmonary nodule and results of the long term treatment.

View all citing articles on Scopus

^☆: Presented in part at the 30th annual meeting of the American Society for Therapeutic Radiology and Oncology, New Orleans, October 1988.

View full text

Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy☆

Abstract

Radiother. Oncol.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Radiother. Oncol.

Int. J. Radiat. Oncol. Biol. Phys.